Defects in the interferon-gamma and interleukin-12 pathways.
about
Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunityMendelian genetics of human susceptibility to fungal infectionTuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells.CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibitionNontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapyLymphadenitis caused by infection with an isoniazid- and rifampin-resistant strain of Mycobacterium bovis BCG in an infant with IFN-γ/IL-12 pathway defect.Two cases illustrating successful adjunctive interferon-γ immunotherapy in refractory disseminated coccidioidomycosis.Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon.Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550).Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.Live attenuated S. Typhimurium vaccine with improved safety in immuno-compromised mice.A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humansIκBζ augments IL-12- and IL-18-mediated IFN-γ production in human NK cells.Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment.The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes.Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds.Genkwadaphnin induces IFN-γ via PKD1/NF-κB/STAT1 dependent pathway in NK-92 cells.Investigating the Role of Gene-Gene Interactions in TB Susceptibility.Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis.Characterization of an IL-12 p40/p35 Truncated Fusion Protein That can Inhibit the Action of IL-12.Recent insights into the pathobiology of innate immune deficienciesAntimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.Genetic Susceptibility to Fungal Infections in Humans.Association between IFN-γ +874A/T and IFN-γR1 (-611A/G, +189T/G, and +95C/T) Gene Polymorphisms and Chronic Periodontitis in a Sample of Iranian PopulationRole of cytokines in head and neck squamous cell carcinoma.A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections.Immunity to microbes: lessons from primary immunodeficiencies.A novel X-linked recessive form of Mendelian susceptibility to mycobaterial disease.Granulomatous skin lesions, severe scrotal and lower limb edema due to mycobacterial infections in a child with complete IFN-γ receptor-1 deficiency.Mycobacterium intracellulare Pulmonary Disease with Endobronchial Caseation in a Patient Treated with Methotrexate.A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in miceIncreased expression of suppressor of cytokine signaling-1 (SOCS-1): A mechanism for dysregulated T helper-1 responses in HIV-1 disease.Control of T helper cell differentiation through cytokine receptor inclusion in the immunological synapse.Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindredsRefractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency.Review paper: modulation of mononuclear phagocyte function by Mycobacterium avium subsp. paratuberculosis.Nontuberculous mycobacterial pulmonary infections in Non-HIV patients.Novel Mutation of Interferon-γ Receptor 1 Gene Presenting as Early Life Mycobacterial Bronchial Disease.Addressing diagnostic challenges in primary immunodeficiencies: laboratory evaluation of Toll-like receptor- and NF-κB-mediated immune responses.
P2860
Q26862947-04A45493-80B6-4F84-87DF-6566A1DF9963Q27022250-DAB91A2F-E5E0-4509-8A6F-24BF9C3AEF43Q30370903-70FE0C25-D26A-4522-8E49-D2524B7E5E25Q33762255-96B42743-0162-4630-AA56-626B60529CD0Q33836681-9674C52E-B6D5-44DE-8307-DD73340785DAQ33852374-C2C299DE-A3B5-4DC6-833A-1FE4E7D4763AQ33921735-AB62163A-F42C-4969-ACB9-5DB5381B4E16Q33962690-6CA4521A-EC38-41AE-B47E-D450EEA2ED70Q34169114-BD0D1A6D-08AA-4551-B9C8-F898597B258BQ34192317-ACEBEF4D-AD50-43AE-AD84-36585AA0AFC3Q34429033-A11E1D4A-F036-4AC1-A801-9C9D0793AA09Q34627078-5381EF0B-0210-4A0A-ACE6-1A024F83169CQ34707156-D131A847-CE11-4EF6-BC5F-829331F93E29Q34757266-CA374B48-AF73-4D51-9F39-F39216B5C927Q34891783-534A5F56-8342-4ADE-BCFC-6A9CD4FC8F2DQ35046817-B55817A8-308E-44FC-92D0-A2BC0F6BC47DQ35527121-042A377B-6097-46D6-AF76-8A096D92C7FCQ35616623-D49886D9-C71A-4682-89A4-33232E59A0FBQ35935923-5A1B63A5-E08B-4EF9-B026-036388BEADDDQ36030315-0D3D213B-CF97-4028-A954-9432CC79BAF1Q36125707-DF68D77D-DEEB-4197-8684-9FB9EAD91B63Q36156072-FDE77F90-993D-428F-A095-303B7C82D139Q36266425-3FE19B2B-7E86-42CD-A1D1-A53987FFF03EQ36330018-2C9A2D26-452E-476C-A018-7C2E9E50C4FBQ36448411-96E3845F-5D40-4E4C-AC1A-61DD52D575B9Q36613975-75BCE366-F249-46CC-97C5-F485694328BBQ36654943-0CAABD4C-E2EF-4165-B234-322CC23DE91CQ36729350-31EFF1DD-B56F-4D05-974E-FC674953E125Q37004799-75E7D3E8-1D7B-49A2-A8D0-AC7BF3EA5836Q37056155-DF7655B7-0E0F-41F6-8B01-34938F130AC9Q37090053-4756C277-A3B8-45EA-933E-AB361684F576Q37155566-AE967F11-DF03-4078-B879-F6958A5D0235Q37226913-30C0EB59-52FD-406C-8172-EC9496D0993DQ37273309-8C7B8CD4-1822-4BBD-88D3-96F939007D6FQ37294396-D58B5708-FE80-441C-AF94-5C84C1ACC55DQ37314463-2C1C75D0-BC05-40D3-BD20-718454D5CD32Q37317741-7CFDE7E3-D15A-4B4E-B668-83717BEFA4A4Q37329897-A3C48167-D454-4C49-98A5-6D148874E43DQ37405831-7AFBF777-8910-4BCB-9A34-3386701FE186Q38188634-4FF59D4C-1EFC-4A69-933F-8AF3CABB9B9B
P2860
Defects in the interferon-gamma and interleukin-12 pathways.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Defects in the interferon-gamma and interleukin-12 pathways.
@ast
Defects in the interferon-gamma and interleukin-12 pathways.
@en
type
label
Defects in the interferon-gamma and interleukin-12 pathways.
@ast
Defects in the interferon-gamma and interleukin-12 pathways.
@en
prefLabel
Defects in the interferon-gamma and interleukin-12 pathways.
@ast
Defects in the interferon-gamma and interleukin-12 pathways.
@en
P2860
P1476
Defects in the interferon-gamma and interleukin-12 pathways.
@en
P2093
Sergio D Rosenzweig
Steven M Holland
P2860
P356
10.1111/J.0105-2896.2005.00227.X
P577
2005-02-01T00:00:00Z